glp-1 vs tirzepatide Semaglutide Tirzepatide: Which Wins for Weight Loss? Not sure whether Semaglutide or

Association between diabetes and subsequent Parkinson disease: a record-linkage cohort study

In clinical trials of Liraglutide (1.8 mg) and Albiglutide (50 mg), liraglutide was superior for reducing HbA1c, but was more likely to lose weight in patients

When you eat, these cells secrete GLP-1 into your bloodstream, where it performs several critical functions: Regulates appetite by signaling satiety to your brain Slows gastric emptying to extend feelings of fullness Supports healthy blood sugar levels already within normal range Enhances insulin secretion in response to meals The problem

The bio-availability of the DPP-4 inhibitors is very good and the pharmacodynamic- as well as the pharmacokinetic characteristics lead to the above mentioned clinically sufficient DPP-4 inhibition with once daily dosing (only vildagliptin has to be dosed twice daily) (18, 19)

Some patients achieve satisfactory results at intermediate doses, while others require maximum approved doses